Brief: Prime Medicine Prices Upsized Initial Public Offering Of 10.3 Mln Common Shares At $17.00/Share
20/10/2022 02:53
Oct 19 (Reuters) - Prime Medicine Inc PRME.O :
* PRIME MEDICINE ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC
OFFERING
* PRICES UPSIZED INITIAL PUBLIC OFFERING OF 10.3 MILLION
COMMON
SHARES AT A PRICE TO PUBLIC OF $17.00 PER SHARE
Source text for Eikon: ID:nBw8GK50Pa
Further company coverage: PRME.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease